Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Barsch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Gastrointestinal Cancer|January 14, 2026
Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?Maryam Barsch, Elaine-Pashupati Dopfer, Anne Maria Schultheis, et al.
Oncology Research and Treatment|March 13, 2025
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2024Carolin Krekeler, Verena Turco, Annabel Helga Sophie Alig, et al.
Pathologie (Heidelberg, Germany)|June 27, 2025
[Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board]Elaine-Pashupati Dopfer, Matthias Fahrner, Johanna Thiery, et al.
United European Gastroenterology Journal|September 20, 2024
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohortKatharina Mitzlaff, Martha M Kirstein, Christian Müller, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Gastrointestinal Cancer|January 14, 2026
Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How?Maryam Barsch, Elaine-Pashupati Dopfer, Anne Maria Schultheis, et al.
Oncology Research and Treatment|March 13, 2025
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2024Carolin Krekeler, Verena Turco, Annabel Helga Sophie Alig, et al.
Pathologie (Heidelberg, Germany)|June 27, 2025
[Trop-2 expression in solid tumors : Expanded protein diagnostics within the molecular tumor board]Elaine-Pashupati Dopfer, Matthias Fahrner, Johanna Thiery, et al.
United European Gastroenterology Journal|September 20, 2024
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohortKatharina Mitzlaff, Martha M Kirstein, Christian Müller, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Journal of Hepatology|April 3, 2022
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinomaMaryam Barsch, Henrike Salié, Alexandra Emilia Schlaak, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Pageof 1